Impact of focal segmental glomerulosclerosis over the past decade

Keng Thye Woo, Choong Meng Chan, Marjorie Foo, Cynthia Ciwei Lim, Jason Choo, Y Chin, Esther Wei Ling Teng, Irene Mok, Jia Liang Kwek, Hui Zhuan Tan, Alwin Hwai Liang Loh, Jiunn Wong, Terence P. Kee, Hui Lin Choong, Han Khim Tan, Kok‐Seng Wong, Puay Hoon Tan, Chieh Suai TanClinical 2023 · DOI

Abstract

Our data suggest that in FSGS, one of the significant components of the disease is the vascular and tubular damage, apart from the underlying glomerular pathology, resulting in varying responses to therapy, and the difference is reflected in inherently poorer response to immunosuppressant therapy in those without nephrotic syndrome as opposed to those with nephrotic syndrome, who responded to immunosuppressant therapy (IST) with stabilization of renal function and had less blood vessel and tubular lesions.
BibTeX
@inproceedings{woo2023impact,
  author = {Keng Thye Woo and Choong Meng Chan and Marjorie Foo and Cynthia Ciwei Lim and Jason Choo and Y Chin and Esther Wei Ling Teng and Irene Mok and Jia Liang Kwek and Hui Zhuan Tan and Alwin Hwai Liang Loh and Jiunn Wong and Terence P. Kee and Hui Lin Choong and Han Khim Tan and Kok‐Seng Wong and Puay Hoon Tan and Chieh Suai Tan},
  title = {{Impact of focal segmental glomerulosclerosis over the past decade}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.5414/cn111022},
}

Loading related content...

Figure